InvestorsHub Logo
Followers 594
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

Re: Rkmatters post# 15429

Tuesday, 04/19/2016 1:22:06 PM

Tuesday, April 19, 2016 1:22:06 PM

Post# of 34576
$TPIV 80 person study will be to compare TPIV200 vs Chemotherapy Drug: Cyclophosphamide

https://clinicaltrials.gov/ct2/show/study/NCT02593227#contacts

Sarah Cannon Research Institute Active, Nashville, Tennessee

http://sarahcannon.com/


Cyclophosphamide:
http://druginfo.nlm.nih.gov/drugportal/rn/6055-19-2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News